{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T16:21:44Z","timestamp":1758039704870,"version":"3.44.0"},"reference-count":9,"publisher":"Cambridge University Press (CUP)","issue":"1","license":[{"start":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T00:00:00Z","timestamp":1757548800000},"content-version":"unspecified","delay-in-days":253,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["ASHE"],"published-print":{"date-parts":[[2025]]},"abstract":"<jats:title>Abstract<\/jats:title>\n\t  <jats:p>We assessed implementation of a local intravenous-to-enteral antimicrobial transition protocol for pediatric hematology\/oncology and bone marrow transplant patients with bacterial or candidal bloodstream infection and central line removal. Among 76 cases, 57 met protocol criteria. Enteral antimicrobials were used in 29 (50.8%) cases meeting eligibility criteria for conversion.<\/jats:p>","DOI":"10.1017\/ash.2025.10136","type":"journal-article","created":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T04:41:39Z","timestamp":1757565699000},"source":"Crossref","is-referenced-by-count":0,"title":["Assessment of IV-to-PO conversion guideline implementation in pediatric cancer and bone marrow transplant patients after line removal for bloodstream infection"],"prefix":"10.1017","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-5973-4965","authenticated-orcid":false,"given":"Adam W.","family":"Brothers","sequence":"first","affiliation":[{"name":"Seattle Children\u2019s Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-5331-5895","authenticated-orcid":false,"given":"Darcy B.","family":"Campbell","sequence":"additional","affiliation":[{"name":"University of Washington School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7026-1930","authenticated-orcid":false,"given":"Victoria J.L.","family":"Konold","sequence":"additional","affiliation":[{"name":"Seattle Children\u2019s Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle M.","family":"Palmer","sequence":"additional","affiliation":[{"name":"Seattle Children\u2019s Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-5743-3741","authenticated-orcid":false,"given":"Daniel J.","family":"Pak","sequence":"additional","affiliation":[{"name":"Seattle Children\u2019s Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1856-6841","authenticated-orcid":false,"given":"Matthew P.","family":"Kronman","sequence":"additional","affiliation":[{"name":"Seattle Children\u2019s Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6215-7765","authenticated-orcid":false,"given":"Derry R.","family":"McDonald","sequence":"additional","affiliation":[{"name":"Seattle Children\u2019s Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer J.","family":"Wilkes","sequence":"additional","affiliation":[{"name":"University of Washington"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3755-4010","authenticated-orcid":false,"given":"Scott J.","family":"Weissman","sequence":"additional","affiliation":[{"name":"Seattle Children\u2019s Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"56","published-online":{"date-parts":[[2025,9,11]]},"reference":[{"key":"S2732494X25101368_ref4","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofac706"},{"key":"S2732494X25101368_ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jgar.2021.11.014"},{"key":"S2732494X25101368_ref6","doi-asserted-by":"publisher","DOI":"10.3390\/pharmacy10010016"},{"key":"S2732494X25101368_ref2","doi-asserted-by":"publisher","DOI":"10.1186\/s13756-016-0161-0"},{"key":"S2732494X25101368_ref3","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2020.0555"},{"key":"S2732494X25101368_ref7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0207413"},{"key":"S2732494X25101368_ref8","first-page":"5057","article-title":"Oral fluoroquinolones for definitive treatment of gram-negative bacteremia in cancer patients","volume":"29","author":"Tossey","year":"2021","journal-title":"Support Care Cancer"},{"key":"S2732494X25101368_ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2021.10.007"},{"key":"S2732494X25101368_ref1","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0b013e318236f473"}],"container-title":["Antimicrobial Stewardship &amp; Healthcare Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S2732494X25101368","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T04:41:40Z","timestamp":1757565700000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S2732494X25101368\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":9,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025]]}},"alternative-id":["S2732494X25101368"],"URL":"https:\/\/doi.org\/10.1017\/ash.2025.10136","relation":{},"ISSN":["2732-494X"],"issn-type":[{"type":"electronic","value":"2732-494X"}],"subject":[],"published":{"date-parts":[[2025]]},"article-number":"e207"}}